Search Results 461-470 of 13681 for BPC-157

  1. A Study Of CA-4948 In Patients With Relapsed Or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

    This is a multi-center, open-label trial of orally administered CA-4948 monotherapy in adult patients with Relapsed or Refractory NHL. The trial will be ...

  2. A Study To Evaluate Preoperative Oral Microbiota-Based Investigational New Drug To Target Immune Response In Patients With Operable Stage I-III Breast Cancer - Mayo Clinic

    A Study To Evaluate Preoperative Oral Microbiota-Based Investigational New Drug To Target Immune Response In Patients With Operable Stage I-III Breast Cancer.

  3. To Assess The Efficacy, Safety, And Tolerability Of INCB000928 In Participants With Fibrodysplasia Ossificans Progressiva - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Fecal Microbiota Spores Live-Brpk Capsules And/or Fecal Microbiota Live-Jslm Suspension For Recurrent Clostridioides Difficile Infection - Mayo Clinic

    The purpose of this study is to evaluate the experience and clinical outcomes for patients with recurrent Clostridioides difficile infection (CDI) who received ...

  5. Polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride (oral route) - Mayo Clinic

    Polyethylene glycol 3350, sodium ascorbate, sodium sulfate, ascorbic acid, sodium chloride, and potassium chloride combination is used to cleanse the bowels ...

  6. Onasemnogene abeparvovec-brve (intrathecal route) - Side effects & uses - Mayo Clinic

    Onasemnogene abeparvovec-brve injection is used to treat spinal muscular atrophy (SMA) with confirmed mutation in survival motor neuron 1 (SMN1) gene. Spinal ...

  7. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of ABT-494 For The Induction Of Symptomatic And Endoscopic Remission In Subjects With Moderately To Severely Active Crohn's Disease Who Have Inadequately Responded To Or Are Intolerant To Immunomodulators Or Anti-TNF Therapy - Mayo Clinic

    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of ABT-494 For The Induction Of Symptomatic And Endoscopic Remission In Subjects With ...

  8. Study Of Oral LOXO-338 In Patients With Advanced Blood Cancers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Trial To Evaluate The Efficacy And Safety Of MOR208 With Bendamustine (BEN) Versus Rituximab (RTX) With BEN In Adult Patients With Relapsed Or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    MOR00208 is an investigational drug. RTX and BEN are both approved in many countries for the treatment of lymphomas. The combination of both is considered and ...

  10. Inotuzumab Ozogamicin And Post-Induction Chemotherapy In Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, And B-LLy - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...